Christoph Winterhalter

CBO at AGC Biologics

Speaker

Christoph Winterhalter assumed the role of Chief Business Officer in March 2024 and oversees corporate strategy, business development, new business initiatives and global marketing for the AGC Biologics CDMO network. He brings 30 years of experience in the life science, CDMO and biopharmaceutical outsourcing space, and previously served as the Senior Vice President Business Development EMEA for AGC Biologics.
Christoph joined AGC Biologics in 2018 and has contributed significantly to the company’s growth over the past six years. Before AGC Biologics, he most recently served as the Senior Vice President of Global Business Development for the CDMO Rentschler Biopharma. Reporting directly to the CEO, he guided the company’s global sales and development strategy and created strategic manufacturing alliances with leading global biopharmaceutical companies. While there, he was instrumental in tripling the top-line sales numbers for the company. Before that, Christoph worked at Wacker Chemie AG supporting its Life Science businesses for nearly 20 years, most recently serving as Vice President of Biosolutions for the Americas. At Wacker he managed teams focused on Research and Development (R&D), Project Management, GMP Production, Business Development, and Marketing.
Christoph received a degree in Microbiology and his Doctorate from the Technical University of Munich.